Citigroup Maintains Buy on Applied Therapeutics, Raises Price Target to $44

Citigroup maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $29 to $44.

Benzinga · 01/09/2020 16:37

Citigroup maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $29 to $44.